GE HealthCare Technologies Inc (GEHC)

GE HealthCare Technologies Inc. is a healthcare equipment and supplies company that develops, manufactures, and markets products, services, and digital solutions used in patient diagnosis, treatment, and monitoring. The company operates through four segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. Its offerings include molecular imaging, CT and MR systems, X-ray equipment, ultrasound, image-guided therapies, patient monitoring, diagnostic cardiology, maternal infant care, anesthesia products, and diagnostic agents used in radiology and nuclear medicine. The company also provides contrast media pharmaceuticals and molecular imaging agents. GE HealthCare Technologies Inc. was incorporated in 2022, previously operated as GE Healthcare Holding LLC, and adopted its current name in December 2022. It is headquartered in Chicago, Illinois, and serves customers in the United States, Canada, and international markets.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-GEHC
$79.81
28.1% Upside
Undervalued
$79.33
27.4% Upside
Undervalued
Good
July 24, 2026
August 14, 2026
0.14
0.2%
July 28, 2026
14.9x
2.7x
1.4x
28.581 B
36.959 B
26.9%
99.7%
2.7
3.4%
79.6%
Valuation • Fair Value

GE HealthCare Technologies Inc (NASDAQ-GEHC) Fair Value by Valuation Model

Compare the primary fair value estimate for GE HealthCare Technologies Inc (NASDAQ-GEHC) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$79.81

Estimated upside of 28.1% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$86.89

Discounted cash flow valuation reference.

Ben Graham Formula Value

$46.56

Classic Ben Graham valuation formula reference.

DDM Fair Value

$98.51

Dividend discount model valuation reference.

EPV Fair Value

$61.56

Earnings power value estimate.

Comps Fair Value

$69.55

Comparable-company valuation reference.

Analyst Price Target

$79.33

Analysts imply upside of 27.4%.

How to read these valuation models

Use this section to compare the primary fair value estimate for GE HealthCare Technologies Inc (NASDAQ-GEHC) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for GE HealthCare Technologies Inc (NASDAQ-GEHC)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

20.979 B

Current operating scale indicator.

Revenue Forecast

21.812 B

Forward revenue estimate.

EBITDA

3.522 B

Current operating profitability reference.

EBITDA Forecast

3.911 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review GE HealthCare Technologies Inc (NASDAQ-GEHC) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for GE HealthCare Technologies Inc (NASDAQ-GEHC)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.35

No elevated caution signal from this screen.

Altman Z-Score

2.7

Intermediate risk zone.

FCF / Net Income

79.6%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for GE HealthCare Technologies Inc (NASDAQ-GEHC). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for GE HealthCare Technologies Inc (NASDAQ-GEHC)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 28, 2026

Days to Earnings

7

Dividend Payment Date

August 14, 2026

Ex-Dividend Date

July 24, 2026

Dividend Yield

0.2%

Income yield reference.

Upcoming Dividend

0.14

Upcoming distribution amount.

Payment Type

Cash

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

3.4%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for GE HealthCare Technologies Inc (NASDAQ-GEHC), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

GE HealthCare Technologies Inc (NASDAQ-GEHC) Stock Forecast & Technical Outlook

Review GE HealthCare Technologies Inc (NASDAQ-GEHC) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for GE HealthCare Technologies Inc (NASDAQ-GEHC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for GE HealthCare Technologies Inc (NASDAQ-GEHC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for GE HealthCare Technologies Inc (NASDAQ-GEHC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for GE HealthCare Technologies Inc (NASDAQ-GEHC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for GE HealthCare Technologies Inc (NASDAQ-GEHC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for GE HealthCare Technologies Inc (NASDAQ-GEHC)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, GE HealthCare Technologies Inc (NASDAQ-GEHC) has a Buy consensus, with 10 buy, 5 hold and 0 sell recommendations in the current data set.

Buy 10
Hold 5
Sell 0
FAQ Fast Investor Answers

GE HealthCare Technologies Inc (NASDAQ-GEHC) Stock FAQ

Quick answers about GE HealthCare Technologies Inc (NASDAQ-GEHC) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$79.81
Estimated upside 28.1%
Valuation Rating
Undervalued
Estimated upside of 28.1%
Analyst Target
$79.33
Implied upside 27.4%
Financial Health
Good
Current financial-health read

The current fair value estimate for GE HealthCare Technologies Inc (NASDAQ-GEHC) is $79.81. This implies an estimated upside of 28.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 28.1% versus the current market price.

The available analyst price target for GE HealthCare Technologies Inc (NASDAQ-GEHC) is $79.33. The analyst target implies estimated upside of 27.4%.

The current financial health read for GE HealthCare Technologies Inc (NASDAQ-GEHC) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for GE HealthCare Technologies Inc (NASDAQ-GEHC) is July 28, 2026.

Based on the current data, dividend yield is 0.2%, upcoming dividend amount is 0.14, ex-dividend date is July 24, 2026, payment date is August 14, 2026.

The current P/E ratio listed for GE HealthCare Technologies Inc (NASDAQ-GEHC) is 14.9x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for GE HealthCare Technologies Inc is 28.581 B.

The current enterprise value listed for GE HealthCare Technologies Inc is 36.959 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for GE HealthCare Technologies Inc is NASDAQ-GEHC, and the stock is listed on NASDAQ.

GE HealthCare Technologies Inc (NASDAQ-GEHC) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for GE HealthCare Technologies Inc is 26.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for GE HealthCare Technologies Inc is 99.7%. Free float helps investors understand how much of the share base is available for public trading.